Article Details

Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Given Consensus Rating of "Buy" by Analysts

Retrieved on: 2021-05-07 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Given Consensus Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 3,157,387 shares of the company's stock worth $384,727,000 after buying an additional 454,506 shares in the last quarter.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up